|Podcasts|January 7, 2021
Episode 73: Biotech’s IPO Steamroll
Author(s)Elaine Quilici
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like.
Advertisement
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why Do a Significant Number of GLP-1 Users Stop Taking the Medication in the First Year?
2
Neurocrine Enters $2.9 Billion Agreement to Acquire Soleno Therapeutics
3
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
4
Bringing the Bayesian Method to Clinical Trials: Q&A with Dr. Stacy Lindborg
5